Taiwan's Academia Sinica said Friday that it has screened out protease inhibitors of the COVID-19 coronavirus, which could eventually lead to the development of targeted drugs to stop the virus from replicating itself in patients' bodies.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Premier-designate Cho picks labor, health, environment ministers (update)
04/19/2024 04:26 PM - Business
U.S. dollar closes sharply higher on Taipei forex market
04/19/2024 04:11 PM - Politics
Over NT$20 billion to be allocated to Hualien earthquake relief
04/19/2024 03:48 PM - Politics
Computer-aided Han Kuang war games to refer to recent conflicts
04/19/2024 03:23 PM - Business
Taiwan shares close down 3.81%
04/19/2024 02:02 PM